Tag: AMD

FDA, Regulations

FDA grants clearance for Endogena’s age-related macular degeneration treatment

October 25, 2023

Via: Pharma Times

The US Food and Drug Administration (FDA) has granted clearance for Endogena Therapeutics’ investigational new drug application to treat geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD). The FDA clearance will enable Endogena to progress with the […]

Clinical Trials, Research and Development

Age-Related Macular Degeneration Linked to High-Risk Cardiovascular Disease

November 18, 2022

Via: GEN

A new study from New York Eye and Ear Infirmary of Mount Sinai demonstrates that patients with a specific form of age-related macular degeneration (AMD) may have either underlying heart damage from heart failure and heart attacks, or advanced heart […]

FDA, Regulations

FDA Approves Genentech’s Susvimo for Wet AMD

October 29, 2021

Via: Biopharm International

Genentech, a member of the Roche Group, announced on Oct. 22nd, 2021, that FDA had approved Susvimo (100 mg/mL ranibizumab injection) for the treatment of wet, or neovascular, age-related macular degeneration (AMD), a condition that can lead to rapid and […]

Mergers and Acquisitions

Novartis acquires Arctos Medical to develop gene therapy programme

September 22, 2021

Via: European Pharmaceutical Review

Novartis have announced that it has acquired Arctos Medical, adding a pre-clinical optogenetics-based Adeno-associated viruses (AAV) gene therapy programme and Arctos’ proprietary technology to its ophthalmology portfolio. The acquisition aims to more efficiently develop treatments for patients with vision loss […]

Cell and Gene Therapy, Industry

Janssen buys up eye disorder gene therapy asset from Hemera Biosciences

December 2, 2020

Via: FierceBiotech

Janssen is tapping little-known and privately held Hemera Biosciences for a new gene therapy aimed at reversing a severe disease. The deal, financials of which are not being shared, is for the investigational phase 1 gene therapy HMR59, which is […]